Risk of Myocardial Infarction and Stroke With Single or Repeated Doses of Intravitreal Bevacizumab in Age-Related Macular Degeneration  

Oleh:

Etminan, Mahyar ; Maberley, David A. ; Babiuk, David W. ; Carleton, Bruce C.

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: American Journal of Ophthalmology (keterangan: ada di ClinicalKey) vol. 163 (Mar. 2016), page 53–58.
Topik: Myocardial Infarction; Stroke; Intravitreal Bevacizumab
Fulltext: A12 v163 p53 kelik2016.pdf (158.96KB)

Ketersediaan

Perpustakaan FK Nomor Panggil: A12.K Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

Purpose: To examine the risk of myocardial infarction and stroke with single and repeated doses of intravitreal bevacizumab in wet age-related macular degeneration (AMD). Design: Nested case-control study and retrospective cohort study. Methods: SETTING: Two patient cohorts from British Columbia, Canada. STUDY POPULATION: Patients with wet AMD. INTERVENTION: For the cohort study, patients who received the first intravitreal bevacizumab; for the nested case-control study, repeated injections of intravitreal bevacizumab. MAIN OUTCOME MEASURES: Myocardial infarction for the retrospective cohort study; myocardial infarction and stroke for the nested case-control study. Results: In the cohort analysis, there were 2564 AMD subjects not on a vascular endothelial growth factor (VEGF) inhibitor and 5644 subjects receiving intravitreal bevacizumab. The rate of myocardial infarction (MI) among bevacizumab users was 11/1000 person-years, compared to 14.9/1000 person-years in nonusers. The adjusted rate ratio (RR) for MI was 0.70 (95% confidence interval [CI]: 0.50–1.00) and 0.74 (0.46–1.20) for the propensity score–adjusted analysis. In the nested case-control analysis there were 7452 new users of VEGF inhibitors, within which there were 313 cases of MI with 3130 matched controls. The adjusted RR for MI among those receiving 3 or more injections compared to those receiving fewer than 3 was 0.71 (95% CI: 0.41–1.22). Also in the nested case-control analysis, the adjusted RR for stroke was 0.81 (95% CI: 0.39–1.65) for those receiving =4 injections vs those receiving fewer than 4 injections. Conclusion: Single or repeated doses of intravitreal bevacizumab were not shown to increase the risk of myocardial infarction or stroke in patients with wet AMD.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali